Subtype
Adult Central Nervous System Neoplasm
CI-CAN-00000416Explore in graph →
Non-malignant32 active trials1 evidence items
- NCIt
- C5131
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000416Explore in graph →
Clinical trials
204 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02613988 | Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas | unknown | N/A | 100 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT04553341 | Induction of Cortical Plasticity | unknown | N/A | 40 | Technical University of MunichOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05850377 |
| 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas |
| unknown |
| — |
| 90 |
| Sociedad de Lucha Contra el Cáncer del EcuadorOTHER |
| 1 |
| May 9, 2023 |
| clinicaltrials |
| NCT05267158 | The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA)(COIMBRA) | unknown | — | 1,000 | UMC UtrechtOTHER | 1 | Sep 6, 2022 | clinicaltrials |
| NCT05333588 | The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. | unknown | Early Phase 1 | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Apr 19, 2022 | clinicaltrials |
| NCT03932981 | First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression(TEMOTRAD01) | unknown | Phase 2 | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT04909307 | Surveillance of Association of Immune Status and Prognosis of CNS Germ Cell Tumor Survivors | unknown | — | 150 | Chengcheng GuoOTHER | 1 | Jun 3, 2021 | clinicaltrials |
| NCT03025893 | A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme(STELLAR) | unknown | Phase 2 / Phase 3 | 100 | Amsterdam UMC, location VUmcOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03771625 | Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell Tumors | unknown | — | 30 | Beijing Neurosurgical InstituteOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT01424839 | Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors(SIOPCNSGCTII) | unknown | Phase 4 | 400 | University Hospital MuensterOTHER | 1 | Jun 4, 2015 | clinicaltrials |
| NCT01806155 | Prevalence of Post-craniotomy Headache in Siriraj Hospital | unknown | — | 200 | Mahidol UniversityOTHER | 1 | Aug 19, 2013 | clinicaltrials |
Data updated 22 days agoSource updated May 14, 2024source: clinicaltrials